OxTalks is Changing
OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Maximising the Commercial Value of your University Research - Avoiding IP Pitfalls: Selling reagents, understanding MTAs and 3rd party rights
Increasingly academic researchers find themselves signing MTAs to access reagents, providing reach through rights to 3rd parties and/or making use of research technologies (such as CRISPR) that are subject to active patent protection. Although this can accelerate research progress, it also provide significant baggage for your innovations, and may well impact on the potential for commercial development of your ideas.
This seminar will discuss the challenges faced, and aims to identify some smart strategies to plan for and avoid some of the pitfalls.
Date:
14 December 2016, 14:00
Venue:
Kennedy Institute of Rheumatology, Headington OX3 7FY
Venue Details:
Lecture Hall
Speaker:
Various Speakers
Organising department:
Medical Sciences Division
Organiser:
Alison Brindle (Medical Sciences Division, University of Oxford)
Part of:
Medical Sciences Division Events
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Alison Brindle
